Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blenheim Chalcot is a UK-based venture builder and management company that creates and scales technology businesses, primarily in enterprise SaaS and generative AI. Its activities span sectors including financial services, education, media and marketing, public services, health, and sports. The organization is not a biotech, pharma, or healthcare company, although it has some exposure to health and healthcare technology through parts of its portfolio. It operates as an active builder and incubator rather than a therapeutic product developer, and no drug pipeline or clinical-stage assets were identified. The requested name "Blenheim Calcot" appears to be a misspelling of "Blenheim Chalcot."
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blenheim Calcot.